Committed. Integrated. Global.
Accord is a leading, vertically-integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India, under the parent name of Intas Pharmaceuticals.
Accord’s success lies in the cumulative, strategic initiatives made in the areas of manufacturing, R & D, biotechnology and global operations for over four decades. Our R & D operation is staffed with a distinguished scientific team with diverse skill sets and educational backgrounds. Our state-of-the-art labs and manufacturing infrastructure provide the right environment for true innovation.
As a co-developer of several of the first biosimilar filings in the U.S., we possess not only the R & D and manufacturing expertise required for achieving success with such programs, but also the knowledge required to navigate uncertain regulatory pathways in the regulated markets.
To-date, we have commercialized 14 biologic products in the domestic Indian market, and two in the European markets. Continual R & D initiatives in areas such as Oncology, Rheumatology, Auto-Immune, Nephrology, Ophthalmology and Plasma derived product based therapies have strengthened niche and complex product pipelines in many of the company’s global markets.